Is US bird flu outbreak in cattle a global risk to humans?
Nevada: US authorities have said the detection of a different strain of avian influenza, the D1.1 genotype, in dairy cows in January proves that bird flu has now spread from wild birds into cattle twice in an outbreak that started in late 2023.
The genotype refers to the genetic makeup of a virus within a group of virus types. In this case, it is the highly pathogenic avian influenza (HPAI) A H5N1.
In March 2024, authorities in the US confirmed the outbreak had originated from genotype B3.13. That type has infected over 950 cattle herds in 16 US states and spread to Canada.
D1.1 was detected in milk collected as part of a surveillance programme launched in December 2024.
Is bird flu spreading internationally?
Yes, it appears that bird flu from the current US outbreak may have spread beyond North America.
In January, UK authorities confirmed a second human case of H5N1 avian influenza. The first was detected in 2022, the UK Health Security Agency (UKHSA) said.
"The risk of avian flu to the public remains very low despite this confirmed case," said Susan Hopkins, chief medical adviser at the UKHSA, in a statement on January 27.
However, many governments have been buying up vaccine stocks and ramping up precautionary measures in response to the circulating virus.
The bird flu variant outbreak has mainly affected the US, with infections among cattle, people and pets.
Though no direct, human-to-human transmission cases were recorded up to January 2025, there are concerns the H5N1 variant could be one mutation away from becoming a major public health concern.
A study published in the journal Science
in December 2024 found that a single genetic change to the circulating H5N1 had enabled it to jump more easily from other mammals to humans.
"We're particularly worried about pigs because we know from many other outbreaks that pigs are a mixing vessel for influenza viruses," Meghan Davis, an environmental health researcher at Johns Hopkins Bloomberg School of Public Health, told DW's Science Unscripted podcast.
Is a new pandemic brewing?
Before the outbreak of SARS-CoV-2, the virus that causes COVID-19, health scientists warned there was a risk of an emerging pandemic.
Ultimately, it was a novel coronavirus, not an influenza strain, that triggered the pandemic. But the chance of a global influenza-driven event was — and is — cause for concern.
"With H5N1, there's a big unknown," Peter Jay Hotez, dean of the National School of Tropical Medicine at the Baylor College of Medicine in the US state of Texas, told Science Unscripted.
"We know there's a likelihood that there could be a significant bird flu pandemic, maybe resembling the 1918 flu pandemic," Hotez said, "but we can't say when that will be."
Other nations are increasing surveillance and precautionary measures. The UK government is known to have ordered at least 5 million doses of an H5 influenza vaccine. In November 2024, one case of H5N1 was confirmed at a poultry farm in Cornwall, in the southwest of England.
"I agree with what the UK did because it's not like you can press a button and suddenly have millions of doses of [H5 vaccine] appear," Hotez said. "Making flu vaccines in the traditional way is a slow process."
Hotez described the rate of pandemic threats as having a "regular cadence," pointing to SARS in 2002 and MERS in 2012, which were dangerous but did not balloon to a global scale.
A pandemic was declared due to H1N1 influenza in 2009, though its impact didn't match that of COVID-19.
"We have to get ready for H5N1. We've also got this rise in Ebola and other filovirus [severe hemorrhagic] infections that we're seeing — we have to be ready for that," Hotez said. "And we're starting to see [a rise in] mosquito-transmitted virus infections like dengue and chikungunya and then Zika virus infections both in Southern Europe and the southern United States."
Trump's health advisers are 'contrarians, activists'
Scientists and health experts in the United States have expressed concern about several choices that President Donald Trump has made for his new administration.
Among Trump's picks are Robert F. Kennedy Jr. to lead the Department of Health and Human Services and Dave Weldon for the top job of the Centers for Disease Control and Prevention.
Kennedy and Weldon are known for their opposition to vaccination.
Although Trump was president at the outset of the COVID pandemic and led massive investments in vaccine supply security through programs such as Operation Warp Speed, Hotez said the absence of people with established experience in health issues in Trump's new administration is concerning.
"[In Trump's first administration] they were pretty mainstream public health physicians and public health scientists, but this new round is something that's quite different — they're contrarians, they're activists, they've openly campaigned against vaccines and interventions," Hotez said.
Health experts in other nations are closely watching how H5N1 is handled in North America.
"The current incidence of infection in the US demands we closely study samples of viruses from humans and other animals," said Martin Schwemmle, a virologist at Freiburg University Medical Center.
The European Centre for Disease Prevention and Control said in a November 2024 report
that it was continuing to monitor the US and Canadian situations "together with partner organizations in Europe and will continue to update its assessment of the risk for humans ... as new information becomes available."
It also recommended increased surveillance and monitoring of people exposed to avian influenza and that doctors and nurses ask patients whether they have had any contact with animals.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Observer
16-04-2025
- Observer
WHO countries strike landmark agreement on tackling future pandemics
Years of negotiations culminated early Wednesday with countries agreeing the text of a landmark accord on how to tackle future pandemics, aimed at avoiding the mistakes made during the Covid-19 crisis. After more than three years of talks and one last marathon session, weary delegates at the World Health Organization's headquarters finally sealed the deal at around 2:00 am (0000 GMT) Wednesday. "Tonight marks a significant milestone in our shared journey towards a safer world," said WHO chief Tedros Adhanom Ghebreyesus. "The nations of the world made history in Geneva today." Five years after the emergence of Covid-19, which killed millions of people, devastated economies and upturned health systems, a sense of urgency hung over the talks, with new threats lurking -- including H5N1 bird flu, measles, mpox and Ebola. The final stretch of the talks also took place under the shadow of cuts to US foreign aid spending and threatened tariffs on pharmaceuticals. Negotiators stumbled over the agreement's Article 11, which deals with transferring technology for pandemic health products towards developing nations. During the Covid-19 pandemic, poorer states accused rich nations of hoarding vaccines and tests. Countries with large pharmaceutical industries have strenuously opposed the idea of mandatory tech transfers, insisting they must be voluntary. But it appeared the obstacle could be overcome by adding that any transfer needed to be "mutually agreed". The core of the agreement is a proposed Pathogen Access and Benefit-Sharing System (PABS), aimed at allowing the swift sharing of pathogen data with pharmaceutical companies, enabling them to quickly start working on pandemic-fighting products. In the end, the 32-page agreement was entirely highlighted in green, indicating all of it had been fully approved by WHO member states. "It's adopted," negotiations co-chair Anne-Claire Amprou announced, to thunderous applause. "In drafting this historic agreement, the countries of the world have demonstrated their shared commitment to preventing and protecting everyone, everywhere, from future pandemic threats." The finalised text will now be presented for sign-off at the WHO's annual assembly next month. While taking measures to coordinate pandemic prevention, preparedness and response could be costly, "the cost of inaction is much bigger", he insisted. "Virus is the worst enemy. (It) could be worse than a war." The United States, which has thrown the global health system into crisis by slashing foreign aid spending, was absent. US President Donald Trump ordered a withdrawal from the United Nations' health agency and from the pandemic agreement talks after taking office in January. However, the US absence, and Trump's threat to slap steep tariffs on pharmaceutical products, still hung over the talks, making manufacturers and governments more jittery. But in the end, countries reached consensus. As the congratulatory speeches continued on towards daybreak at the WHO HQ, Eswatini's representative cautioned that "whilst we celebrate this moment, we need not rest on our laurels. "The real work begins now."
Times of Oman
02-03-2025
- Times of Oman
Scientists crack the code for why locusts swarm
Berlin: After months of building, the biggest locust swarm recorded in 70 years swept across 10 countries in East Africa in spring 2020. The damage to crops was estimated at $8.5 billion (€8.1 billion) in a region where 23 million people face severe food insecurity. During these invasions, desert locusts (Schistocerca gregaria) eat their own weight in food every day. The biblical-scale plague ate through 160,000,000 kilograms of food a day — enough to feed 800,000 people for a year. Scientists have been trying to understand how individual locusts gather in swarms for decades. Knowing their behaviour would help with predicting and managing outbreaks. A new model, published today in the journal Science, casts light on the hive mind of locusts. The study describes how individual locusts transition from behaving as solitary animals to giant swarms with collective motion. "Our work provides a new perspective for considering collective motion in animals, and robotics too," lead author Iain Couzin, a neurobiologist at Centre of the Advanced Study of Collective Behaviour, Konstanz, Germany. "One application is a new class of predictive models of how and where swarms move. Future research on this could impact the livelihoods of 1 in 10 people on the planet," Couzin told DW. A new model of swarming, using insect VR Locusts swarms have threatened food security for millennia and have played their part in history — locusts were one of the 10 plagues brought upon Egypt as retold in the Book of Exodus. For decades scientists have been trying to understand how individual locusts move en masse. In 2006, Couzin developed a model explaining how locusts would march together in a line when they swarm. "This model came from particle physics and suggested that individuals bump into each other randomly, then flow together all in the same direction if there is a high density of individuals," said Couzin. Study author Sercan Sayin began probing this model in locusts using a virtual reality (VR) stage set for locusts. Sayin had the insects walk on a ball surrounded by panoramic views on screens. These landscapes reconstructed the world in 3D to make the locusts think they were in a swarm, Sayin said. But he couldn't replicate the 2006 findings that animal density was responsible for locusts forming swarms. Vision cues swarming behaviours Field experiments in Kenya during the huge 2020 swarm showed certain visual cues caused locusts to behave with collective movements when swarming. "Previously we'd thought that bumping into each other caused swarms, but our experiments showed that it's vision that's important," said Couzin. "We found instead that [swarm behaviours] are triggered by the type of sensory information around them, not how many locusts they're surrounded by." Jan Ache, a neurobiologist at the University of Wuerzburg, Germany, who was not involved in the study, said the research expands a mathematical model of swarms which acknowledges the individuality of locusts. "In order for locusts to have collective motion, they need very basic forms of cognitive processing — where insects integrate their own position relative to the position of those around them, then actively follow other locusts," he said. This occurs in individual locusts, but when they come together in crowds it creates the emergent effect of a swarm. How the brain makes decisions Ache said locusts are fascinating to study because they exist in two different states: solitary or swarming. Normally avoidant, the insects switch into marching bands after several hours of crowding. "When they change from one type to the other, the brain is in two different states. In each state, the same neurons drive very different behaviors — like being attracted to or repelled by other locusts," Ache said. Ultimately, the findings are about decisions-making in neuronal systems, Couzin said. "At the basic level, there's competition between groups of neurons in the brain. The brain must come to a consensus and make a decision about movement," Couzin said. In other words, when there's a conflict in the brain, neuronal pathways compete until a decision is made when one pathway "wins" over the other. In their experiments, the visual cues of other locusts in front acted as a target causing the navigation systems to pull the organism in the same direction. "This is very similar to opinion dynamics in humans, where people adopt similar opinions to others and dismiss other opinions," said Couzin. Predicting swarms and crowds? Couzin said the new model has important implications for predicting swarms in the real world. "If we were able to create a model predicting how swarms move, we were using the wrong model before. The implication is new ways to predict how and where swarms move based on a biological understanding of collective motion," said Couzin. It could also help to understand how fish move in schools; birds move in flocks and potentially how mammals move in herds. Couzin is also applying their research in robots, creating collective motion in autonomous vehicles. Couzin said their findings are worth considering in human crowds too, perhaps to help prevent crowd crushes, but "it's too early to make any claims as those experiments haven't been done."
Times of Oman
11-02-2025
- Times of Oman
Is US bird flu outbreak in cattle a global risk to humans?
Nevada: US authorities have said the detection of a different strain of avian influenza, the D1.1 genotype, in dairy cows in January proves that bird flu has now spread from wild birds into cattle twice in an outbreak that started in late 2023. The genotype refers to the genetic makeup of a virus within a group of virus types. In this case, it is the highly pathogenic avian influenza (HPAI) A H5N1. In March 2024, authorities in the US confirmed the outbreak had originated from genotype B3.13. That type has infected over 950 cattle herds in 16 US states and spread to Canada. D1.1 was detected in milk collected as part of a surveillance programme launched in December 2024. Is bird flu spreading internationally? Yes, it appears that bird flu from the current US outbreak may have spread beyond North America. In January, UK authorities confirmed a second human case of H5N1 avian influenza. The first was detected in 2022, the UK Health Security Agency (UKHSA) said. "The risk of avian flu to the public remains very low despite this confirmed case," said Susan Hopkins, chief medical adviser at the UKHSA, in a statement on January 27. However, many governments have been buying up vaccine stocks and ramping up precautionary measures in response to the circulating virus. The bird flu variant outbreak has mainly affected the US, with infections among cattle, people and pets. Though no direct, human-to-human transmission cases were recorded up to January 2025, there are concerns the H5N1 variant could be one mutation away from becoming a major public health concern. A study published in the journal Science in December 2024 found that a single genetic change to the circulating H5N1 had enabled it to jump more easily from other mammals to humans. "We're particularly worried about pigs because we know from many other outbreaks that pigs are a mixing vessel for influenza viruses," Meghan Davis, an environmental health researcher at Johns Hopkins Bloomberg School of Public Health, told DW's Science Unscripted podcast. Is a new pandemic brewing? Before the outbreak of SARS-CoV-2, the virus that causes COVID-19, health scientists warned there was a risk of an emerging pandemic. Ultimately, it was a novel coronavirus, not an influenza strain, that triggered the pandemic. But the chance of a global influenza-driven event was — and is — cause for concern. "With H5N1, there's a big unknown," Peter Jay Hotez, dean of the National School of Tropical Medicine at the Baylor College of Medicine in the US state of Texas, told Science Unscripted. "We know there's a likelihood that there could be a significant bird flu pandemic, maybe resembling the 1918 flu pandemic," Hotez said, "but we can't say when that will be." Other nations are increasing surveillance and precautionary measures. The UK government is known to have ordered at least 5 million doses of an H5 influenza vaccine. In November 2024, one case of H5N1 was confirmed at a poultry farm in Cornwall, in the southwest of England. "I agree with what the UK did because it's not like you can press a button and suddenly have millions of doses of [H5 vaccine] appear," Hotez said. "Making flu vaccines in the traditional way is a slow process." Hotez described the rate of pandemic threats as having a "regular cadence," pointing to SARS in 2002 and MERS in 2012, which were dangerous but did not balloon to a global scale. A pandemic was declared due to H1N1 influenza in 2009, though its impact didn't match that of COVID-19. "We have to get ready for H5N1. We've also got this rise in Ebola and other filovirus [severe hemorrhagic] infections that we're seeing — we have to be ready for that," Hotez said. "And we're starting to see [a rise in] mosquito-transmitted virus infections like dengue and chikungunya and then Zika virus infections both in Southern Europe and the southern United States." Trump's health advisers are 'contrarians, activists' Scientists and health experts in the United States have expressed concern about several choices that President Donald Trump has made for his new administration. Among Trump's picks are Robert F. Kennedy Jr. to lead the Department of Health and Human Services and Dave Weldon for the top job of the Centers for Disease Control and Prevention. Kennedy and Weldon are known for their opposition to vaccination. Although Trump was president at the outset of the COVID pandemic and led massive investments in vaccine supply security through programs such as Operation Warp Speed, Hotez said the absence of people with established experience in health issues in Trump's new administration is concerning. "[In Trump's first administration] they were pretty mainstream public health physicians and public health scientists, but this new round is something that's quite different — they're contrarians, they're activists, they've openly campaigned against vaccines and interventions," Hotez said. Health experts in other nations are closely watching how H5N1 is handled in North America. "The current incidence of infection in the US demands we closely study samples of viruses from humans and other animals," said Martin Schwemmle, a virologist at Freiburg University Medical Center. The European Centre for Disease Prevention and Control said in a November 2024 report that it was continuing to monitor the US and Canadian situations "together with partner organizations in Europe and will continue to update its assessment of the risk for humans ... as new information becomes available." It also recommended increased surveillance and monitoring of people exposed to avian influenza and that doctors and nurses ask patients whether they have had any contact with animals.
